BioTimes, Inc. is an innovative biotechnology company. We aim to develop novel technologies and tools that will drive new scientific discoveries, provide high quality raw materials for clinical diagnostics, and enable novel therapeutic development.

​

Our unique expertise in recombinant proteins and antibodies allows enhanced performance of target proteins for intended applications. We use technologies that allows our multiplex immunoassays significantly improve detection sensitivities, robustness in performance, and production consistency.  

​

Our patent pending technology for Multivalent proteins enabled quick detection of SARS CoV-2 antibodies.